We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights The Home Depot, Advanced Micro Devices, Pfizer, The Cigna Group and Live Nation Entertainment
Read MoreHide Full Article
For Immediate Release
Chicago, IL – December 13, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: The Home Depot, Inc. (HD - Free Report) , Advanced Micro Devices, Inc. (AMD - Free Report) , Pfizer Inc. (PFE - Free Report) , The Cigna Group (CI - Free Report) and Live Nation Entertainment, Inc. (LYV - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Top Stock Reports for Home Depot, AMD and Pfizer
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc., Advanced Micro Devices, Inc. and Pfizer Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Home Depot shares have done modestly better than rival Lowe's this year (+5.7% vs. +4.1%), but both have lagged the S&P 500 index's +21% gain in the year-to-date period.
The Zacks analyst believes that the "One Home Depot" investment plan, which focuses on expanding supply chain facilities and technological enhancement to the digital experience have been a major aid. Also, the closely connected retail strategy and underlying technology infrastructure have boosted web traffic.
Yet, a decrease in lumber prices and pressures in several big-ticket discretionary categories have pressured the company's top and bottom line.
Advanced Micro Devices shares have outperformed the Zacks Electronics - Semiconductors industry over the past year (+87.6% vs. +47.0%). The Zacks analyst believes that strong adoption of Ryzen and fourth-gen EPYC CPU have been driving the company's data center and client revenues.
However, weak Gaming and embedded revenues have weigh down on the company. Gaming declined due to lower semi-custom revenues, while the embedded segment suffered from lower performance in the communications market.
Shares of Pfizer have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (-46.1% vs. +3.7%). Per the Zacks analyst, there are concerns about the company's growth drivers beyond its COVID related products because of stiff competition. Also, Comirnaty vaccine and Paxlovid oral pill, two of its flagship COVID-19 products have witnessed low demand.
However, new launches like Abrysvo, Velsipity, Penbraya, Zavzpret and new acquisitions provide sufficient diversification in its product portfolio currently. Huge profits from its COVID products have strengthened its cash position, which is being used to make such acquisitions, increase dividends, buy back shares and reduce debt.
Other noteworthy reports we are featuring today include The Cigna Group and Live Nation Entertainment, Inc..
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights The Home Depot, Advanced Micro Devices, Pfizer, The Cigna Group and Live Nation Entertainment
For Immediate Release
Chicago, IL – December 13, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: The Home Depot, Inc. (HD - Free Report) , Advanced Micro Devices, Inc. (AMD - Free Report) , Pfizer Inc. (PFE - Free Report) , The Cigna Group (CI - Free Report) and Live Nation Entertainment, Inc. (LYV - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Top Stock Reports for Home Depot, AMD and Pfizer
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc., Advanced Micro Devices, Inc. and Pfizer Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Home Depot shares have done modestly better than rival Lowe's this year (+5.7% vs. +4.1%), but both have lagged the S&P 500 index's +21% gain in the year-to-date period.
The Zacks analyst believes that the "One Home Depot" investment plan, which focuses on expanding supply chain facilities and technological enhancement to the digital experience have been a major aid. Also, the closely connected retail strategy and underlying technology infrastructure have boosted web traffic.
Yet, a decrease in lumber prices and pressures in several big-ticket discretionary categories have pressured the company's top and bottom line.
(You can read the full research report on Home Depot here >>>)
Advanced Micro Devices shares have outperformed the Zacks Electronics - Semiconductors industry over the past year (+87.6% vs. +47.0%). The Zacks analyst believes that strong adoption of Ryzen and fourth-gen EPYC CPU have been driving the company's data center and client revenues.
However, weak Gaming and embedded revenues have weigh down on the company. Gaming declined due to lower semi-custom revenues, while the embedded segment suffered from lower performance in the communications market.
(You can read the full research report on Advanced Micro Devices here >>>)
Shares of Pfizer have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (-46.1% vs. +3.7%). Per the Zacks analyst, there are concerns about the company's growth drivers beyond its COVID related products because of stiff competition. Also, Comirnaty vaccine and Paxlovid oral pill, two of its flagship COVID-19 products have witnessed low demand.
However, new launches like Abrysvo, Velsipity, Penbraya, Zavzpret and new acquisitions provide sufficient diversification in its product portfolio currently. Huge profits from its COVID products have strengthened its cash position, which is being used to make such acquisitions, increase dividends, buy back shares and reduce debt.
(You can read the full research report on Pfizer here >>>)
Other noteworthy reports we are featuring today include The Cigna Group and Live Nation Entertainment, Inc..
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.